@prefix np: . @prefix npx: . @prefix ns1: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { rdf:OBJECT rdfs:label "a control group to fully assess treatment success or failure" . rdf:OBJECT-POSITION rdfs:label "(103, 111)" . rdf:PREDICATE rdfs:label "have" . rdf:SUBJECT rdfs:label "this analysis" . rdf:SUBJECT-POSITION rdfs:label "(103, 111)" . rdfs:label "control group" . ns1:have ; rdfs:label "analysis" . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" . sub:assertion prov:generatedAtTime "2023-06-12T11:58:36.028136"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377 . rdf:Statement rdfs:label "Baseline Characteristics by Respiratory Status Pre-Tocilizumab Administration [Image: see text] Subgroup Analysis [Image: see text] Outcome by Baseline IL-6 Levels [Image: see text] Overall mortality in our patients was 43%; however, our's sample size was small and this analysis did not have a control group to fully assess treatment success or failure." . rdfs:ABSTRACT-UID rdfs:label "bnp8ln4c" . rdfs:TRIPLE-UID rdfs:label "bnp8ln4c-TRIPLE-ABSTRACT-7" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }